Product Code: MRR-7DB6EB7
Title:
Animal Biotechnology Market Research Report by Product (Diagnostic Tests, Drugs, Reporductive & Genetic Produtcs, and Vaccines), by Application (Development of Animal Pharmaceuticals, Food Safety and Drug Development, and Preventive Care for Animals) - Global Forecast to 2025 - Cumulative Impact of COVID-19.
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
- 1. The Global Animal Biotechnology Market is expected to grow from USD 22,654.79 Million in 2020 to USD 32,421.49 Million by the end of 2025.
- 2. The Global Animal Biotechnology Market is expected to grow from EUR 19,864.15 Million in 2020 to EUR 28,427.77 Million by the end of 2025.
- 3. The Global Animal Biotechnology Market is expected to grow from GBP 17,659.27 Million in 2020 to GBP 25,272.35 Million by the end of 2025.
- 4. The Global Animal Biotechnology Market is expected to grow from JPY 2,417,840.16 Million in 2020 to JPY 3,460,194.54 Million by the end of 2025.
- 5. The Global Animal Biotechnology Market is expected to grow from AUD 32,897.76 Million in 2020 to AUD 47,080.31 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Animal Biotechnology to forecast the revenues and analyze the trends in each of the following sub-markets:
- Based on Product, the Animal Biotechnology Market studied across Diagnostic Tests, Drugs, Reporductive & Genetic Produtcs, and Vaccines.
- Based on Application, the Animal Biotechnology Market studied across Development of Animal Pharmaceuticals, Food Safety and Drug Development, and Preventive Care for Animals.
- Based on Geography, the Animal Biotechnology Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Animal Biotechnology Market including Abbott Laboratories, Bayer AG, Biogenesis Bago, Boehringer Ingelheim GmbH, Elanco, Genus plc, Ivaoes, LLC, Merck & Co., Inc.,, Merial, Neogen Corporation, Novartis, Pfizer, Inc., Sanofi, Santa Cruz Biotechnology, Inc., SCYNEXIS, Inc., Trans Ova Genetics, VetDC, Inc., Virbac Inc., Z-Link Biotech, and Zoetis Inc..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch™ FPNV Positioning Matrix:
The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Biotechnology Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch™ Competitive Strategic Window:
The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
- 1. Market Penetration: Provides comprehensive information on the market offered by the key players
- 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
- 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
- 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
- 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
- 1. What is the market size and forecast of the Global Animal Biotechnology Market?
- 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Animal Biotechnology Market during the forecast period?
- 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Animal Biotechnology Market?
- 4. What is the competitive strategic window for opportunities in the Global Animal Biotechnology Market?
- 5. What are the technology trends and regulatory frameworks in the Global Animal Biotechnology Market?
- 6. What are the modes and strategic moves considered suitable for entering the Global Animal Biotechnology Market?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Stakeholders
2. Research Methodology
- 2.1. Research Process
- 2.1.1. Define: Research Objective
- 2.1.2. Determine: Research Design
- 2.1.3. Prepare: Research Instrument
- 2.1.4. Collect: Data Source
- 2.1.5. Analyze: Data Interpretation
- 2.1.6. Formulate: Data Verification
- 2.1.7. Publish: Research Report
- 2.1.8. Repeat: Report Update
- 2.2. Research Execution
- 2.2.1. Initiation: Research Process
- 2.2.2. Planning: Develop Research Plan
- 2.2.3. Execution: Conduct Research
- 2.2.4. Verification: Finding & Analysis
- 2.2.5. Publication: Research Report
- 2.3. Research Outcome
3. Executive Summary
- 3.1. Introduction
- 3.2. Market Outlook
- 3.3. Product Outlook
- 3.4. Application Outlook
- 3.5. Geography Outlook
- 3.6. Competitor Outlook
4. Market Overview
- 4.1. Introduction
- 4.2. Cumulative Impact of COVID-19
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising focus toward cloning and transgenic animals
- 5.1.1.2. Increasing R&D by major players
- 5.1.1.3. Rising popularity and acceptance coupled with the regulatory approvals
- 5.1.2. Restraints
- 5.1.2.1. High cost associated with R&D
- 5.1.2.2. Ethical issues associated with the animal biotechnology products
- 5.1.3. Opportunities
- 5.1.3.1. Increasing animal meat consumption and the rising per capita animal healthcare expenditure
- 5.1.3.2. Transgenic livestock for agriculture
- 5.1.4. Challenges
- 5.1.4.1. Potential negative impacts on animal welfare throughout the process
- 5.2. Porters Five Forces Analysis
- 5.2.1. Threat of New Entrants
- 5.2.2. Threat of Substitutes
- 5.2.3. Bargaining Power of Customers
- 5.2.4. Bargaining Power of Suppliers
- 5.2.5. Industry Rivalry
6. Global Animal Biotechnology Market, By Product
- 6.1. Introduction
- 6.2. Diagnostic Tests
- 6.3. Drugs
- 6.4. Reporductive & Genetic Produtcs
- 6.5. Vaccines
7. Global Animal Biotechnology Market, By Application
- 7.1. Introduction
- 7.2. Development of Animal Pharmaceuticals
- 7.3. Food Safety and Drug Development
- 7.4. Preventive Care for Animals
8. Americas Animal Biotechnology Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
9. Asia-Pacific Animal Biotechnology Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. South Korea
- 9.10. Thailand
10. Europe, Middle East & Africa Animal Biotechnology Market
- 10.1. Introduction
- 10.2. France
- 10.3. Germany
- 10.4. Italy
- 10.5. Netherlands
- 10.6. Qatar
- 10.7. Russia
- 10.8. Saudi Arabia
- 10.9. South Africa
- 10.10. Spain
- 10.11. United Arab Emirates
- 10.12. United Kingdom
11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.1.1. Quadrants
- 11.1.2. Business Strategy
- 11.1.3. Product Satisfaction
- 11.2. Market Ranking Analysis
- 11.3. Market Share Analysis
- 11.4. Competitor SWOT Analysis
- 11.5. Competitive Scenario
- 11.5.1. Merger & Acquisition
- 11.5.2. Agreement, Collaboration, & Partnership
- 11.5.3. New Product Launch & Enhancement
- 11.5.4. Investment & Funding
- 11.5.5. Award, Recognition, & Expansion
12. Company Usability Profiles
- 12.1. Abbott Laboratories
- 12.2. Bayer AG
- 12.3. Biogenesis Bago
- 12.4. Boehringer Ingelheim GmbH
- 12.5. Elanco
- 12.6. Genus plc
- 12.7. Ivaoes, LLC
- 12.8. Merck & Co., Inc.,
- 12.9. Merial
- 12.10. Neogen Corporation
- 12.11. Novartis
- 12.12. Pfizer, Inc.
- 12.13. Sanofi
- 12.14. Santa Cruz Biotechnology, Inc.
- 12.15. SCYNEXIS, Inc.
- 12.16. Trans Ova Genetics
- 12.17. VetDC, Inc.
- 12.18. Virbac Inc.
- 12.19. Z-Link Biotech
- 12.20. Zoetis Inc.
13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
比較リスト
